Literature DB >> 24710497

Valvular disease: Implications of the new AHA/ACC valvular disease guidelines.

Bernard Iung1, Alec Vahanian1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24710497     DOI： 10.1038/nrcardio.2014.42

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Guidelines on the management of valvular heart disease (version 2012).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Iung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

2.  Simplification of the prophylaxis of endocarditis: we were right!

Authors:  Xavier Duval
Journal:  Arch Cardiovasc Dis       Date:  2013-03-01       Impact factor: 2.340

3.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  J Am Coll Cardiol       Date:  2014-03-03       Impact factor: 24.094

4.  ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences.

Authors:  Patrizio Lancellotti; Raphael Rosenhek; Philippe Pibarot; Bernard Iung; Catherine M Otto; Pilar Tornos; Erwan Donal; Bernard Prendergast; Julien Magne; Giovanni La Canna; Luc A Piérard; Gerald Maurer
Journal:  Eur Heart J       Date:  2013-01-04       Impact factor: 29.983

Review 5.  Epidemiology of valvular heart disease in the adult.

Authors:  Bernard Iung; Alec Vahanian
Journal:  Nat Rev Cardiol       Date:  2011-01-25       Impact factor: 32.419

6.  Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis.

Authors:  D Massel; S H Little
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

7.  ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

Authors:  Raphael Rosenhek; Bernard Iung; Pilar Tornos; Manuel J Antunes; Bernard D Prendergast; Catherine M Otto; Arie Pieter Kappetein; Janina Stepinska; Jens J Kaden; Christoph K Naber; Esmeray Acartürk; Christa Gohlke-Bärwolf
Journal:  Eur Heart J       Date:  2011-03-15       Impact factor: 29.983

8.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.

Authors:  Bernard Iung; Gabriel Baron; Eric G Butchart; François Delahaye; Christa Gohlke-Bärwolf; Olaf W Levang; Pilar Tornos; Jean-Louis Vanoverschelde; Frank Vermeer; Eric Boersma; Philippe Ravaud; Alec Vahanian
Journal:  Eur Heart J       Date:  2003-07       Impact factor: 29.983

9.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

10.  A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.

Authors:  A G Turpie; M Gent; A Laupacis; Y Latour; J Gunstensen; F Basile; M Klimek; J Hirsh
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.